Published in Neurology on March 01, 1987
Axial kinesthesia is impaired in Parkinson's disease: effects of levodopa. Exp Neurol (2010) 1.24
Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features. J Neurol (2010) 1.14
Parkinson's disease shows perceptuomotor asymmetry unrelated to motor symptoms. Neurosci Lett (2007) 1.01
The relationship between visuospatial ability and perceptual motor function in Parkinson's disease. J Neurol Neurosurg Psychiatry (1993) 0.80
The Michelin red guide of the brain: role of dopamine in goal-oriented navigation. Front Syst Neurosci (2014) 0.77
The Effect of Visual Feedback on Writing Size in Parkinson's Disease. Parkinsons Dis (2015) 0.75
Predictors of HVOT performance in Parkinson's disease. Appl Neuropsychol (2011) 0.75
Reliability of three Benton Judgment of Line Orientation short forms in idiopathic Parkinson's disease. Clin Neuropsychol (2013) 0.75
Cerebral cysticercosis presenting with hemichorea. J Neurol Neurosurg Psychiatry (1987) 0.75
Visuospatial impairment in Parkinson's disease: does it exist? J Neurol Neurosurg Psychiatry (1987) 0.75
Neuropsychological profile in early Parkinson's disease: Comparison between patients with right side onset versus left side onset of motor symptoms. Ann Indian Acad Neurol (2016) 0.75
Apnoea testing to confirm brain death in clinical practice. J Neurol Neurosurg Psychiatry (1986) 1.72
Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology (1994) 1.43
A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun (1998) 1.27
Spatial disorientation in right-hemisphere infarction. J Neurol Neurosurg Psychiatry (1982) 1.13
Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 0.94
Recent developments in capillary isoelectric focusing. J Chromatogr A (2008) 0.90
Effect of stimulus orientation on contrast sensitivity in Parkinson's disease. Neurology (1988) 0.90
Effect of levodopa treatment on contrast sensitivity in Parkinson's disease. Ann Neurol (1987) 0.89
Contrast sensitivity in Parkinson's disease. Neurology (1986) 0.89
Capillary electrophoresis-mass spectrometry using noncovalently coated capillaries for the analysis of biopharmaceuticals. Anal Bioanal Chem (2011) 0.89
Factors that influence the occurrence of response variations in Parkinson's disease. Ann Neurol (1987) 0.85
An improved coating for the isolation and quantitation of interferon-gamma in spiked plasma using surface plasmon resonance (SPR). Biosens Bioelectron (2004) 0.84
On-line post-column Diels-Alder derivatization for the determination of vitamin D3 and its metabolites by liquid chromatography/thermospray mass spectrometry. Biol Mass Spectrom (1993) 0.84
Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. J Pharm Biomed Anal (2008) 0.84
Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum (1991) 0.83
Coupling device for desorption of drugs from solid-phase extraction-pipette tips and on-line gas chromatographic analysis. J Chromatogr A (1999) 0.83
Quick titration of pergolide in cotreatment with domperidone is safe and effective. Clin Neuropharmacol (2001) 0.83
Generalised chorea due to digoxin toxicity. Br Med J (Clin Res Ed) (1988) 0.83
On the response of a label-free interferon-gamma immunosensor utilizing electrochemical impedance spectroscopy. Biosens Bioelectron (2004) 0.82
Fibers coated with molecularly imprinted polymers for solid-phase microextraction. Anal Chem (2001) 0.81
Development of an open-tubular trypsin reactor for on-line digestion of proteins. Anal Bioanal Chem (2007) 0.81
Development of an on-line SPR-digestion-nanoLC-MS/MS system for the quantification and identification of interferon-gamma in plasma. Biosens Bioelectron (2008) 0.80
Solid-phase microextraction for the analysis of biological samples. J Chromatogr B Biomed Sci Appl (2000) 0.80
The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial. J Neurol (1994) 0.80
Ion suppression in the determination of clenbuterol in urine by solid-phase extraction atmospheric pressure chemical ionisation ion-trap mass spectrometry. Rapid Commun Mass Spectrom (2003) 0.79
Determination of lidocaine in plasma by direct solid-phase microextraction combined with gas chromatography. J Chromatogr B Biomed Sci Appl (2000) 0.79
Characterization of drug-lysozyme conjugates by sheathless capillary electrophoresis-time-of-flight mass spectrometry. Anal Chim Acta (2011) 0.79
Spatial contrast sensitivity in unilateral cerebral ischaemic lesions involving the posterior visual pathway. Brain (1989) 0.79
On-line coupling of solid-phase extraction with mass spectrometry for the analysis of biological samples. I. Determination of clenbuterol in urine. J Chromatogr A (1999) 0.79
Capillary electrophoresis-mass spectrometry analysis of trehalose-6-phosphate in Arabidopsis thaliana seedlings. Anal Bioanal Chem (2011) 0.78
Visual contrast sensitivity in drug-induced Parkinsonism. J Neurol Neurosurg Psychiatry (1989) 0.78
Spatial contrast sensitivity in benign intracranial hypertension. J Neurol Neurosurg Psychiatry (1988) 0.78
Maximal expiratory and inspiratory flow-volume curves in Parkinson's disease. Am Rev Respir Dis (1989) 0.78
Feasibility of the direct coupling of solid-phase extraction-pipette tips with a programmed-temperature vaporiser for gas chromatographic analysis of drugs in plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.77
A new approach for generic screening and quantitation of potential genotoxic alkylation compounds by pre-column derivatization and LC-MS/MS analysis. Anal Bioanal Chem (2011) 0.77
Improvement of the liquid-chromatographic analysis of protein tryptic digests by the use of long-capillary monolithic columns with UV and MS detection. Anal Bioanal Chem (2007) 0.77
Limbic encephalitis. A rare presentation of the small-cell lung carcinoma. Gen Hosp Psychiatry (1989) 0.77
Investigations into the stabilisation of drugs by sugar glasses: I. Tablets prepared from stabilised alkaline phosphatase. Int J Pharm (2002) 0.76
Optimisation and characterisation of silica-based reversed-phase liquid chromatographic systems for the analysis of basic pharmaceuticals. J Chromatogr A (2000) 0.76
Direct introduction of large-volume urine samples into an on-line immunoaffinity sample pretreatment-capillary gas chromatography system. Anal Chem (1991) 0.76
A case of organic brain syndrome following head injury successfully treated with carbamazepine. Acta Psychiatr Scand (1988) 0.76
Madopar HBS in Parkinson patients with nocturnal akinesia. Clin Neurol Neurosurg (1988) 0.76
Immunoaffinity chromatography for the sample pretreatment of Taxus plant and cell extracts prior to analysis of taxanes by high-performance liquid chromatography. J Chromatogr A (2002) 0.75
Disturbances of spatial perception in a patient with agenesis of the corpus callosum. Neuropsychologia (1983) 0.75
Capillary electrophoresis-mass spectrometry for impurity profiling of basic pharmaceuticals using non-volatile background electrolytes. J Chromatogr A (2007) 0.75
Treatment of hypokinetic rigid syndrome with fluvoxamine maleate. Lancet (1986) 0.75
Capillary electrophoresis-mass spectrometry using an in-line sol-gel concentrator for the determination of methionine enkephalin in cerebrospinal fluid. Talanta (2008) 0.75
Visuospatial impairment in Parkinson's disease: does it exist? J Neurol Neurosurg Psychiatry (1987) 0.75
Cognition in parkinsonism. Neurology (1988) 0.75
[Brain death, a continuing discussion?]. Ned Tijdschr Geneeskd (1987) 0.75
Profiling of cocaine by micellar electrokinetic chromatography. J Capillary Electrophor (2000) 0.75
Open multicenter trial with Madopar HBS in parkinsonian patients. Preliminary assessment after short-term treatment. Eur Neurol (1987) 0.75
Selectivity in capillary electrokinetic separations. Electrophoresis (1999) 0.75
[Epileptic insult developing immediately following administration of propofol]. Ned Tijdschr Geneeskd (1991) 0.75
Simultaneous resolution of overlapping peaks in high-performance liquid chromatography and micellar electrokinetic chromatography with diode array detection using augmented iterative target transformation factor analysis. J Chromatogr A (2005) 0.75
Capillary electrochromatography of basic compounds using octadecyl-silica stationary phases with an amine-containing mobile phase. J Chromatogr A (2000) 0.75
Modification of Parkinson's disease by long-term levodopa treatment. Arch Neurol (1988) 0.75
Adverse effect of benzhexol on memory in Parkinson's disease. Acta Neurol Scand (1988) 0.75
Research spotlight: research at the Biomedical Analysis Group of the University Utrecht, The Netherlands. Bioanalysis (2010) 0.75
Liquid chromatographic determination of oestradiol in serum by pre-column derivatization with dansyl chloride or laryl chloride and peroxyoxalate chemiluminescence detection. J Pharm Biomed Anal (1991) 0.75
Sample extraction detector for the liquid chromatographic determination of secoverine in biological samples. J Chromatogr (1981) 0.75
The use of a pre-column for the direct high-performance liquid chromatographic determination of the anti-depressants clovoxamine and fluvoxamine in plasma. J Chromatogr (1980) 0.75
[Veterinary herd management programme on a beef bull farm (author's transl)]. Tijdschr Diergeneeskd (1978) 0.75
Selective protein removal and desalting using microchip CE. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.75
Multiple solid-phase microextraction. J Chromatogr A (2000) 0.75
[A man with a curved deformity of the hand]. Ned Tijdschr Geneeskd (2017) 0.75
Spatial contrast sensitivity in clinical neurology. Clin Neurol Neurosurg (1988) 0.75
Towards a general approach for the impurity profiling of drugs by micellar electrokinetic chromatography. Electrophoresis (2001) 0.75
Non-equilibrium solid-phase microextraction coupled directly to ion-trap mass spectrometry for rapid analysis of biological samples. Analyst (2002) 0.75
Spatial disorientation in Parkinson's disease: no effect of levodopa substitution therapy. Neurology (1988) 0.75
Capillary electrophoresis with laser-induced fluorescence detection for fast and reliable apolipoprotein E genotyping. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.75
Capillary electrokinetic separation techniques for profiling of drugs and related products. Electrophoresis (2001) 0.75
On-fiber derivatization for direct immersion solid-phase microextraction. Part II. Acylation of amphetamine with pentafluorobenzoyl chloride for urine analysis. Analyst (2002) 0.75
Automated determination of drugs in blood samples after enzymatic hydrolysis using precolumn switching and post-column reaction detection. J Chromatogr (1983) 0.75
Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease. Adv Neurol (1987) 0.75
Evaluation of the programmed temperature vaporiser for large-volume injection of biological samples in gas chromatography. J Chromatogr B Biomed Sci Appl (1999) 0.75
Characterization of human placental alkaline phosphatase by activity and protein assays, capillary electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Chromatogr B Biomed Sci Appl (2001) 0.75
On-line coupling of solid-phase extraction with mass spectrometry for the analysis of biological samples. II. Determination of clenbuterol in urine using multiple-stage mass spectrometry in an ion-trap mass spectrometer. Rapid Commun Mass Spectrom (2000) 0.75
Optimization of dynamic pH junction for the sensitive determination of amino acids in urine by capillary electrophoresis. Anal Bioanal Chem (2011) 0.75
Trace-level determination of 3'-azido-3'-deoxythymidine in human plasma by preconcentration on a silver (I)-thiol stationary phase with on-line reversed-phase high-performance liquid chromatography. J Chromatogr (1989) 0.75
Immunoaffinity pre-column for selective on-line sample pre-treatment in high-performance liquid chromatography determination of 19-nortestosterone. J Chromatogr (1988) 0.75
Resolution optimisation in micellar electrokinetic chromatography using empirical models. J Chromatogr A (2000) 0.75
Recent innovations in the use of charged cyclodextrins in capillary electrophoresis for chiral separations in pharmaceutical analysis. Electrophoresis (2000) 0.75
[Diagnosis of disorders of spatial orientation in children]. Ned Tijdschr Geneeskd (1984) 0.75
Characterisation of reversed-phase liquid chromatography stationary phases for the analysis of basic pharmaceuticals: eluent properties and comparison of empirical test methods. J Chromatogr A (2001) 0.75
A new derivatization reagent for LC-MS/MS screening of potential genotoxic alkylation compounds. J Pharm Biomed Anal (2012) 0.75
Balint's syndrome in a man with border-zone infarcts caused by atrial fibrillation. Clin Neurol Neurosurg (1984) 0.75
Pepsin immobilized in dextran-modified fused-silica capillaries for on-line protein digestion and peptide mapping. Anal Chim Acta (2008) 0.75
Enantioseparation of ofloxacin in urine by capillary electrokinetic chromatography using charged cyclodextrins as chiral selectors and assessment of enantioconversion. Electrophoresis (2001) 0.75
Choice of capillary electrophoresis systems for the impurity profiling of drugs. J Pharm Biomed Anal (1998) 0.75
High throughput therapeutic drug monitoring of clozapine and metabolites in serum by on-line coupling of solid phase extraction with liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.75
Response variations in the treatment of Parkinson's disease. Neurology (1984) 0.75
[Determining the abscence of spontaneous respirations in brain death]. Ned Tijdschr Geneeskd (1987) 0.75
Trace enrichment on a metal-loaded thiol stationary phase in liquid chromatography: effect of analyte structure and pH value on the (de)sorption behaviour. J Pharm Biomed Anal (1989) 0.75
[Improper treatment of patients with parkinsonism due to drug use]. Ned Tijdschr Geneeskd (1982) 0.75
[Antiparkinson agents]. Ned Tijdschr Geneeskd (1987) 0.75